Literature DB >> 36258195

Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy.

Bashdar Mahmud Hussen1,2, Goran Sedeeq Hama Faraj3, Mohammad Fatih Rasul4, Hazha Jamal Hidayat5, Abbas Salihi6, Aria Baniahmad7, Mohammad Taheri8,9, Soudeh Ghafouri-Frad10.   

Abstract

Exosomes are naturally occurring nanosized particles that aid intercellular communication by transmitting biological information between cells. Exosomes have therapeutic efficacy that can transfer their contents between cells as natural carriers. In addition, the exosomal contents delivered to the recipient pathological cells significantly inhibit cancer progression. However, exosome-based tumor treatments are inadequately precise or successful, and various challenges should be adequately overcome. Here, we discuss the significant challenges that exosomes face as drug carriers used for therapeutic targets and strategies for overcoming these challenges in order to promote this new incoming drug carrier further and improve future clinical outcomes. We also present techniques for overcoming these challenges.
© 2022. The Author(s).

Entities:  

Keywords:  Cancer therapy; Drug carrier; Exosomal delivery challenges; Exosome

Year:  2022        PMID: 36258195      PMCID: PMC9580186          DOI: 10.1186/s12935-022-02743-3

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   6.429


  157 in total

Review 1.  Methods for the physical characterization and quantification of extracellular vesicles in biological samples.

Authors:  Déborah L M Rupert; Virginia Claudio; Cecilia Lässer; Marta Bally
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-08-03       Impact factor: 3.770

2.  Liposomes for the sustained drug release in vivo.

Authors:  G Blume; G Cevc
Journal:  Biochim Biophys Acta       Date:  1990-11-02

3.  Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation.

Authors:  Zhuanyun Du; Zhenglan Huang; Xi Chen; Guoyun Jiang; Yuhang Peng; Wenli Feng; Ningshu Huang
Journal:  Exp Hematol Oncol       Date:  2022-06-07

Review 4.  Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action.

Authors:  Thazin Nwe Aung; Zhipeng Qu; R Daniel Kortschak; David L Adelson
Journal:  Int J Mol Sci       Date:  2017-03-17       Impact factor: 5.923

Review 5.  Exosomes: biogenesis, biologic function and clinical potential.

Authors:  Yuan Zhang; Yunfeng Liu; Haiying Liu; Wai Ho Tang
Journal:  Cell Biosci       Date:  2019-02-15       Impact factor: 7.133

6.  Inflammation potentiates miR-939 expression and packaging into small extracellular vesicles.

Authors:  Sujay Ramanathan; Botros B Shenoda; Zhucheng Lin; Guillermo M Alexander; Arthur Huppert; Ahmet Sacan; Seena K Ajit
Journal:  J Extracell Vesicles       Date:  2019-08-06

Review 7.  Review on Strategies and Technologies for Exosome Isolation and Purification.

Authors:  Jiaci Chen; Peilong Li; Taiyi Zhang; Zhipeng Xu; Xiaowen Huang; Ruiming Wang; Lutao Du
Journal:  Front Bioeng Biotechnol       Date:  2022-01-05

8.  Exosomes in Cancer Therapy.

Authors:  Farrukh Aqil; Ramesh C Gupta
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

9.  Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.

Authors:  Shinya Sento; Eri Sasabe; Tetsuya Yamamoto
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs.

Authors:  Yao Lin; Jiahua Wu; Weihuai Gu; Yulei Huang; Zhongchun Tong; Lijia Huang; Jiali Tan
Journal:  Adv Sci (Weinh)       Date:  2018-01-30       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.